Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOrganogenesis Holdings Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2024 | 1 | $0.00 | $0.01 | $0.01 |
| Q3 2024 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2024 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q1 2025 | 1 | $0.02 | $0.02 | $0.02 |
| Q2 2025 | 1 | $0.05 | $0.05 | $0.05 |
| Q3 2025 | 1 | $0.04 | $0.04 | $0.04 |
| Q4 2025 | 1 | $0.04 | $0.04 | $0.04 |
Organogenesis Holdings Inc. Earnings Date And Information
Organogenesis Holdings Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.01125 by $0.07875. The company had revenue of 115.18 M for the quarter and had revenue of 433.14 M for the year. Organogenesis Holdings Inc. has generated $0 earnings per share over the last year ($0.0373 diluted earnings per share) and currently has a price-to-earnings ratio of -57.31. Organogenesis Holdings Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Organogenesis Holdings Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | $0.01 | $0.09 | 0.08 | $108.83 M | $115.18 M |
| 08/08/2024 | Q2 2024 | -$0.02 | -$0.13 | -0.11 | $121.30 M | $130.23 M |
| 05/09/2024 | Q1 2024 | -$0.02 | -$0.02 | 0 | $109.98 M | |
| 02/29/2024 | Q4 2023 | -$0.00 | -$0.00 | -0 | $99.65 M | |
| 11/09/2023 | Q3 2023 | $0.01 | $0.09 | 0.09 | $111.43 M | $108.53 M |
| 08/09/2023 | Q2 2023 | $0.03 | $0.04 | 0.02 | $115.09 M | $117.32 M |
| 05/10/2023 | Q1 2023 | -$0.02 | -$0.02 | -0 | $107.64 M | |
| 03/01/2023 | Q4 2022 | $0.05 | $0.06 | 0.01 | $115.52 M | |
| 11/09/2022 | Q3 2022 | $0.06 | $0.00 | -0.06 | $120.85 M | $116.86 M |
| 08/09/2022 | Q2 2022 | $0.08 | $0.07 | -0.01 | $120.91 M | $121.40 M |
| 05/10/2022 | Q1 2022 | $0.05 | $0.00 | -0.05 | $98.12 M | |
| 03/01/2022 | Q4 2021 | $0.08 | $0.40 | 0.32 | $128.56 M | |
| 11/09/2021 | Q3 2021 | $0.06 | $0.10 | 0.04 | $112.24 M | $113.75 M |
| 08/09/2021 | Q2 2021 | $0.07 | $0.16 | 0.09 | $105.95 M | $123.20 M |
| 05/10/2021 | Q1 2021 | $0.08 | $102.55 M | |||
| 03/16/2021 | Q4 2020 | $0.14 | $0.16 | 0.02 | $106.81 M | |
| 11/09/2020 | Q3 2020 | -$0.08 | $0.20 | 0.28 | $71.95 M | $100.80 M |
| 08/10/2020 | Q2 2020 | -$0.12 | -$0.05 | 0.07 | $58.82 M | $68.96 M |
| 05/11/2020 | Q1 2020 | -$0.12 | -$0.16 | -0.04 | $61.73 M | |
| 03/09/2020 | Q4 2019 | -$0.10 | -$0.05 | 0.06 | $74.65 M |
Organogenesis Holdings Inc. Earnings: FAQ's
When is Organogenesis Holdings Inc.'s earnings date?
Organogenesis Holdings Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
Did Organogenesis Holdings Inc. beat their earnings estimates last
quarter?
In the previous quarter, Organogenesis Holdings Inc. (:ORGO) reported $0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01125 by $0.07875.
How can I listen to Organogenesis Holdings Inc.'s earnings conference
call?
The conference call for Organogenesis Holdings Inc.'s latest earnings report can be listened to online.
How can I read Organogenesis Holdings Inc.'s conference call transcript?
The conference call transcript for Organogenesis Holdings Inc.'s latest earnings report can be read online.
How much revenue does Organogenesis Holdings Inc. generate each year?
Organogenesis Holdings Inc. (:ORGO) has a recorded annual revenue of $433.14 M.
How much profit does Organogenesis Holdings Inc. generate each year?
Organogenesis Holdings Inc. (:ORGO) has a recorded net income of $433.14 M. Organogenesis Holdings Inc. has generated $0.0377 earnings per share over the last four quarters.
What is Organogenesis Holdings Inc.'s price-to-earnings ratio?
Organogenesis Holdings Inc. (:ORGO) has a price-to-earnings ratio of -57.31 and price/earnings-to-growth ratio is -41.55.